Selskabets formål er handel- og fabrikationsvirksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 42 mio. | -21.3 mio. | 330.6 mio. | 155.4 mio. | 64 | |
CVR: 14893695
Secondary names: BEVITRIA A/S, PHARMACIA BIOSYSTEMS A/S, PHARMACIA KØGE CHEMICALS A/S
Previous names: PHARMACIA KØGE CHEMICALS A/S, PK CHEMICALS A/S
4 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 8 companies in Fremstilling af stivelse og stivelsesprodukter
Comparison is based on industry median values
EY Godkendt Revisionspartnerselskab appointed as auditor
Grant Thornton, Godkendt Revisionspartnerselskab resigned as auditor
Michael Frederik Ryde joined the board
Fredrik Alvin Andersson left the board
Stig Løkke Pedersen joined the board
Fredrik Alvin Andersson joined the board
Hans Henrik Gunnar Lidgard left the board
Justin Patrick Pierce left the board
Aaron Michael Wong joined as ADM. DIR.
Justin Patrick Pierce left as ADM. DIR.